1
Enquiry period
with 13.08.2026 11:58
to 22.08.2026 17:00
8 days left
2
Bidding period
with 22.08.2026 17:00
to 28.08.2026 12:00
3
Auction

4
Evaluation
5
Bids have been evaluated
Status Active
Estimated value without VAT 40 000 MDL
Period of clarifications: 13 Aug 2026, 11:58 - 22 Aug 2026, 17:00
Submission of proposals: 22 Aug 2026, 17:00 - 28 Aug 2026, 12:00
Auction start date: will not be used

Supplier technical support:

(+373) 79999801


This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

Categoria de Produs -Tulpină cu genom secvențiat (cu virulență redusă)
Denumirea Tulpinii - Mycobacterium tuberculosis (Zopf) Lehmann and Neumann [H37Ra]
Nivel de biosecuritate – BSL2
Tulpină secvențiată la nivelul genomului -Da
Format Produs -Congelat
Condiții de Depozitare --80°C sau mai rece
Aplicații de laborator – Testarea sensibilității si Controlul Calitatii intern
Seturile vor fi livrate în ambalaj original, securizat, marcat și etichetat de producător, fără preambalare; Instrucțiunile de utilizare a truselor vor conține caracteristicile de performanță și calitate.
Information about customer
Title
Fiscal code/IDNO
Address
MD-2004, MOLDOVA, mun.Chişinău, locality, or.Chisinau, str.T.Ciorba 18A
Web site
---
The contact person
Full name
Chicu Cristina
Contact phone
+37369224911
Purchase data
Date created
Date modified
13 Aug 2026, 11:58
Estimated value (without VAT)
40 000 MDL
Achizitii.md ID
21666534
Type of procedure
Open tender
Award criteria
The lowest price
Delivery address
MD-2004, MOLDOVA, mun.Chişinău, mun.Chişinău, Chisinau
Contract period
5 Nov 2026 02:00 - 19 Nov 2026 02:00
List of positions
1)
Title
Tulpina Mycobacterium tuberculosis subsp. tuberculosis ATCC 25177™, H37Ra CPV: 33600000-6 - Pharmaceutical products
Quantity: 1.0
Unit of measurement: Unitate
Advertising
Documents of the procurement procedure
ITQ 382_GD_T_13.08.2026
Technical Specifications
Invitatie la Tender
13.08.26 11:58
Question's name
Question
At the moment there are no questions to lot
Clarifications